Table 6.
All | Stage I/II | Stage IIIA | Stage IIIB | Stage IIIC | Stage IV | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|
N | N | % | N | % | N | % | N | % | N | % | |
Test Result (in year of Dx) | |||||||||||
Neither Positive * | 14 | 2 | 14.3 | 1 | 7.1 | 1 | 7.1 | 8 | 57.1 | 1 | 7.1 |
Ca-125 Positive (only) | 27 | 3 | 11.1 | 3 | 11.1 | 1 | 3.7 | 17 | 63.0 | 3 | 11.1 |
TVU Positive (only) | 14 | 10 | 71.4 | 1 | 7.1 | 1 | 7.1 | 0 | 0.0 | 2 | 14.3 |
Both Positive | 19 | 4 | 21.1 | 0 | 0.0 | 1 | 5.3 | 12 | 63.2 | 2 | 10.5 |
Not Done | 15 | 2 | 13.3 | 1 | 6.7 | 0 | 0.0 | 10 | 66.7 | 2 | 13.3 |
Study Year/Method of Dx | |||||||||||
Screen Detected at T0 | 18 | 3 | 16.7 | 1 | 5.6 | 2 | 11.1 | 10 | 55.6 | 2 | 11.1 |
Screen Detected at T1 | 13 | 4 | 30.8 | 1 | 7.7 | 1 | 7.7 | 7 | 53.8 | 0 | 0.0. |
Screen Detected at T2 | 14 | 3 | 21.4 | 1 | 7.1 | 0 | 0.0 | 8 | 57.1 | 2 | 14.3 |
Screen Detected at T3 | 15 | 7 | 46.7 | 1 | 6.7 | 0 | 0.0 | 4 | 26.7 | 3 | 20.0 |
Interval * | 19 | 2 | 10.5 | 2 | 10.5 | 1 | 5.3 | 11 | 57.9 | 2 | 10.5 |
Never Screened | 10 | 2 | 20.0 | 0 | 0.0 | 0 | 0.0 | 7 | 70.0 | 1 | 10.0 |
All * | 89 | 21 | 23.6 | 6 | 6.7 | 4 | 4.5 | 47 | 52.8 | 10 | 11.2 |
Staging not available for one subject.
Note – table includes invasive ovarian and peritoneal cancers.